January 19, 2022 Comments Off on New patent for Tetraphase Pharms drug XERAVA Posted in: Patent Added Annual Drug Patent Expirations for XERAVA Xerava is a drug marketed by Tetraphase Pharms and is included in one NDA. There are two patents protecting this drug. This drug has…
The post New patent for Tetraphase Pharms drug XERAVA appeared first on Drug…
January 19, 2022 Comments Off on New patent for Intra-cellular drug CAPLYTA Posted in: Patent Added Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. There are nine patents protecting this drug. CAPLYTA drug price trends.…
The post New patent for Intra-cellular drug CAPLYTA appeared fi…